Newer Therapeutic Targets in Head and Neck Cancers

Plain-language summary

This study uses next generation sequencing to look for potential new treatment targets in patients with head and neck cancer. Patients aged 18 and older with histologically proven primary head and neck cancer may take part. The study has no assigned phase and is still recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Banaras Hindu University

Intervention

Next generation Sequencing

Start date

4/1/2017

Estimated completion

12/31/2027

Countries

India

Related genes

Locations

• Varanasi, India

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Histologically proven cases of primary head and neck cancers.

Exclusion Criteria:

* Patients under 18 years of age
* Pregnant and lactating women
* Multiple cancers or patients with cancer of other sites.